Replies to post #166793 on Avid Bioservices Inc (CDMO)

[stoneroad]

I don't fundamentally disagree. However, I thought SK was pretty clear in stating at this point they were most interested in partnering to get other indications into new or more advanced clinical trials rather than partnering for the recently started NSCLC Phase III.